It looks like you have an older browser that is not supported by this site. Please click here to update.
Posted Aug 31, 20209 min Read
On August 26, 2020, the Centers for Medicare and Medicaid Services (CMS) issued QSO-20-38, providing guidance on the Interim Final Rule released on August 25, 2020, and its requirements for COVID-19 testing of nursing home staff and residents. For IHCA/INCAL’s original summary on the Interim Final Rule, please click here. QSO 20-38 addresses the requirements for when nursing facilities are required to test staff and residents as a requirement of participation in Medicare and Medicaid and provides a revised survey tool for surveyors to assess compliance with the new testing requirements. While the Interim Final Rule was released on August 25, 2020, it is not final until published in the Federal Register. It is expected to be published on Wednesday, September 2, 2020 and at that time the regulation and guidance becomes effective.
Nursing facilities may comply with the testing requirement through the use of rapid point-of-care (POC) diagnostic testing devices or through an arrangement with an offsite laboratory, although IHCA/INCAL is still waiting for further guidance from the Indiana State Department of Health (ISDH) regarding the reporting of POC test results. Only antigen tests and PCR tests are permitted to be used to meet the testing requirement – antibody tests are not permitted.
QSO 20-38 requires testing based on three (3) different triggers:
The frequency of testing once or twice a week presumes availability of POC testing onsite or when off-site testing turnaround time is less than 48 hours. If the 48 hour turnaround time cannot be met due to community testing supply shortages, limited access, or inability of laboratories to process tests within 48 hours, the facility should have documentation of its efforts to obtain quick turnaround test results with the identified laboratory or laboratories and the facility’s contact with the local and state health departments. Please contact Jan Kulik (jkulik@isdh.in.gov) at the Indiana State Department of Health regarding testing issues, and in the alternative Matt Foster ( mfoster@isdh.in.gov).
Importantly, nursing facilities should begin testing all staff the frequency prescribed in the Routine Testing table based on the county positivity rate when available starting August 28th, and facilities should monitor their county positivity rate every other week (i.e., first and third Monday of every month) and adjust the frequency of performing staff testing according to the following:
As a reminder, “staff” includes employees, consultants, contractors, volunteers, and students in the facility’s CNA training program or from affiliated academic institutions. Only individuals who work onsite at the facility will be subject to the testing requirements. Nursing facilities will be required to document each instance of staff or resident COVID-19 testing. If a vendor or volunteer is tested by another source (i.e., their own employer), the facility is required to obtain documentation that the testing was completed.
Generally, for all testing, staff and residents who previously tested positive for COVID-19 do not need to be retested for three (3) months after the date of symptom onset with the prior infection.
Nursing facilities must have procedures in place to address staff who refuse testing. Procedures should ensure that staff who have signs or symptoms of COVID-19 and refuse testing are prohibited from entering the building until the Return to Work Criteria are met. If outbreak testing has been triggered and a staff member refuses testing, the staff member should be restricted from the building until the procedures for outbreak testing have been completed. The facility should follow its occupational health and local jurisdiction policies with respect to any asymptomatic staff who refuse routine testing. Residents (or their designated representative) may exercise their right to decline COVID-19 testing, but if they refuse must be placed in transmission based precautions until criteria for discontinuation of such precautions is met.
Facilities conducting tests under a CLIA certificate of waiver are subject to regulations that require laboratories to report data for all testing completed, for each individual tested. For additional information on these reporting requirements, please click here. In addition to CLIA reporting requirements, nursing facilities should continue to report to NHSN on a weekly basis and to the ISDH within 24 hours of knowledge of a positive COVID-19 case or death confirmed with a PCR test.
Facilities must demonstrate compliance with the testing requirements through the following documentation:
Going forward, surveyors will ask for a facility’s documentation as outlined above and will review a sample of staff and resident records. Surveyors are also encouraged to observe testing in real-time or at least interview an individual responsible for testing to inquire how testing is conducted. If the facility has a shortage of testing supplies, or cannot obtain test results within 48 hours, the surveyor will ask for documentation that the facility contacted state and local health departments to assist with these issues. Noncompliance related to these new testing requirements will be cited at new tag F886. If the facility has documentation that demonstrates their attempts to perform and/or obtain testing in accordance with these guidelines (i.e.., timely contacting state officials, multiple attempts to identify a laboratory that can provide testing results within 48 hours), surveyors should not cite the facility for noncompliance and should inform the state or local health department of the facility’s lack of resources.
IHCA/INCAL staff will continue to review this QSO and update this article as more information is learned and any additional guidance is issues.